NCT05192057View on ClinicalTrials.gov

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions
Nontuberculous Mycobacterial Lung DiseaseMycobacterium Avium Complex
Interventions
DEVICE

Hypertonic Saline inhalation

Hypertonic Saline inhalation is thought to increase mucociliary clearance of the airways

Trial Locations (1)

6225GA

RECRUITING

Radboud University Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT05192057 - Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease | Biotech Hunter | Biotech Hunter